FOCUS 2024

8h30 Welcome breakfast

8h50 Congress introduction: words of the presidents

9h00 JOINT SESSION Management of histological variants
> Prostace Cancer
> Bladder cancer
> Kidney cancer

9h50 Sponsored session

10h35 Coffee break and exhibition visit

11h00 BLADDER CANCER
> Bladder preservation is a SOC in muscule-invasive disease : yes / no
> BCG unresponsavice NMIBC : systemic / intravesical

12h00 Sponsored session

13h00 Lunch and exhibition visit

14h00 Artificial intelligence and radiotherapy: where do we stand?

14h15 Sponsored session

15h15 TESTIS AND PENILE
> RPLND in germ cell tumors: state-of-the-art
> Brachytherapy for penile cancer: state-of-the-art

15h45 Coffee break and exhibition visit

16h15 Sponsored session
17h15 UROTHELIAL CANCER
> Should we intensify upfront BCG treatment in high risk NMIBC
> Multimodal strategy in locally advanced upper urinary tract carcinoma
> Oligometastatic bladder cancer: truth and myths

18h00 SPECIAL GUEST
18h30 End of the day

9h00 Sponsored session

10h00 AFU READ
> SBRT for localized renal cancer
> Renaming ISUP1 : yes / no

10h30 Coffee break and exhibition visit

11h00 Sponsored session

12h00 PROSTATE CANCER
Loco-regional treatment of very high risk PCa (STAMPEDE M0)
> Clinical case
> Surgery (and surgical planning for high risk PCa: LND sparing, nerve preservation)
> Radiotherapy

13h00 Lunch and exhibition visit

14h00 LOCAL TREATMENT OPTIMIZATION
Early detection of prostate cancer
> Why we have to do it
> Why we should better delay the diagnosis
> Organ-sparing RC in female patients
> How to optimize SBRT in localized Pca

15h00 Sponsored session

16h00 MUST READ ARTICLE

16h15 FOCUS MEETS UK CONCUSION

16h30 Congress end